SARS-CoV-2 Transmission Control Measures in the Emergency Department: The Role of Rapid Antigenic Testing in Asymptomatic Subjects.

COVID-19 transmission control asymptomatic COVID-19 emergency department rapid SARS-CoV-2 antigen testing

Journal

Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525

Informations de publication

Date de publication:
23 Apr 2022
Historique:
received: 21 03 2022
revised: 20 04 2022
accepted: 21 04 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 29 5 2022
Statut: epublish

Résumé

Limiting transmission of SARS-CoV-2 from asymptomatic people assumes the paramount importance of keeping fragile subjects protected. We evaluated the utility of rapid SARS-CoV-2 antigen testing in asymptomatic subjects attending emergency departments in non-COVID-19 areas, using a single nasopharyngeal swab specimen collected in universal transport medium to perform both rapid antigen testing and rRT-PCR (used as reference standard) in a cohort of 899 patients. In the overall sample, the rapid antigen test had 43.9% sensitivity, 100% specificity, 100% positive predictive value, 93.6% negative predictive value. Considering subjects with rRT-PCR cycle threshold ≤30, the test had 80.4% sensitivity, 100% specificity, 100% positive predictive value, 98.8% negative predictive value. Considering subjects with rRT-PCR cycle threshold ≤25, the test had 94.7% sensitivity, 100% specificity, 100% positive predictive value and 99.7% negative predictive value. Despite low sensitivity, routine application of rapid antigen testing in the emergency department can lead to isolation in less than 30 min of about a half of asymptomatic COVID-19 subjects assigned to non-COVID-19 areas by clinical triage. The rapid test correctly identified 94.7% of asymptomatic patients with cycle threshold ≤ 25 that are supposed to be more infective; thus, it could be a useful measure to contain viral transmission in non-COVID-19 areas.

Identifiants

pubmed: 35627926
pii: healthcare10050790
doi: 10.3390/healthcare10050790
pmc: PMC9140606
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Microbiol Spectr. 2021 Dec 22;9(3):e0133021
pubmed: 34908473
BMJ. 2022 Mar 9;376:e069761
pubmed: 35264324
Anal Bioanal Chem. 2022 Apr;414(9):2903-2934
pubmed: 35211785
Emerg Med J. 2020 May;37(5):252-254
pubmed: 32321705
Lab Chip. 2021 May 4;21(9):1634-1660
pubmed: 33705507
Lancet. 2022 Jan 29;399(10323):437-446
pubmed: 35065011
JAMA Netw Open. 2021 Dec 1;4(12):e2137257
pubmed: 34905008
Int J Infect Dis. 2020 Oct;99:397-402
pubmed: 32800855
J Med Virol. 2022 Apr;94(4):1723-1727
pubmed: 34873718
Curr Hepatol Rep. 2021;20(4):166-174
pubmed: 34725630
mBio. 2022 Apr 26;13(2):e0297921
pubmed: 35352979
Eur J Emerg Med. 2020 Jun;27(3):174-177
pubmed: 32243317
ACS Sens. 2020 Aug 28;5(8):2283-2296
pubmed: 32627534
Reprod Biomed Online. 2020 Sep;41(3):483-499
pubmed: 32651106
Eur Rev Med Pharmacol Sci. 2021 Jan;25(1):503-517
pubmed: 33506942
J Clin Epidemiol. 2022 May;145:14-19
pubmed: 35041972
MMWR Morb Mortal Wkly Rep. 2022 Apr 01;71(13):489-494
pubmed: 35358168
Nature. 2022 Mar;603(7902):679-686
pubmed: 35042229
BMJ Open. 2022 Jan 31;12(1):e054688
pubmed: 35105642
Clin Microbiol Infect. 2022 May;28(5):734.e1-734.e6
pubmed: 35065265
MedComm (2020). 2021 Dec 16;2(4):838-845
pubmed: 34957469
Diagn Microbiol Infect Dis. 2022 Apr;102(4):115635
pubmed: 35216863
Viruses. 2021 May 01;13(5):
pubmed: 34062916
Emerg Microbes Infect. 2022 Dec;11(1):1-5
pubmed: 34890524
Int J Environ Res Public Health. 2020 May 27;17(11):
pubmed: 32471066
J Virol Methods. 2022 Jan;299:114337
pubmed: 34687785
BMC Health Serv Res. 2021 Oct 25;21(1):1153
pubmed: 34696803
Diagn Pathol. 2022 Apr 13;17(1):36
pubmed: 35414002
Emerg Med Australas. 2020 Jun;32(3):511-514
pubmed: 32255567
Talanta. 2022 Jul 1;244:123409
pubmed: 35390680

Auteurs

Marina Borro (M)

Department of Neurosciences, Mental Health and Sensory Organs (NESMOS), Sapienza University, Via di Grottarossa 1035/1039, 00189 Rome, Italy.
Laboratory of Clinical Biochemistry, Sant'Andrea University Hospital, Via di Grottarossa 1035, 00189 Rome, Italy.

Gerardo Salerno (G)

Department of Neurosciences, Mental Health and Sensory Organs (NESMOS), Sapienza University, Via di Grottarossa 1035/1039, 00189 Rome, Italy.
Laboratory of Clinical Biochemistry, Sant'Andrea University Hospital, Via di Grottarossa 1035, 00189 Rome, Italy.

Andrea Montori (A)

Microbiology Unit, Sant'Andrea University Hospital, Via di Grottarossa 1035, 00189 Rome, Italy.

Andrea Petrucca (A)

Laboratory of Clinical Biochemistry, Sant'Andrea University Hospital, Via di Grottarossa 1035, 00189 Rome, Italy.

Paolo Anibaldi (P)

Medical Direction, Sant'Andrea University Hospital, Via di Grottarossa 1035, 00189 Rome, Italy.

Adriano Marcolongo (A)

General Direction, Sant'Andrea University Hospital, Via di Grottarossa 1035, 00189 Rome, Italy.

Rita Bonfini (R)

Emergency Department Unit, Sant'Andrea University Hospital, Via di Grottarossa 1035, 00189 Rome, Italy.

Maurizio Simmaco (M)

Department of Neurosciences, Mental Health and Sensory Organs (NESMOS), Sapienza University, Via di Grottarossa 1035/1039, 00189 Rome, Italy.
Laboratory of Clinical Biochemistry, Sant'Andrea University Hospital, Via di Grottarossa 1035, 00189 Rome, Italy.

Iolanda Santino (I)

Department of Neurosciences, Mental Health and Sensory Organs (NESMOS), Sapienza University, Via di Grottarossa 1035/1039, 00189 Rome, Italy.
Microbiology Unit, Sant'Andrea University Hospital, Via di Grottarossa 1035, 00189 Rome, Italy.

Classifications MeSH